Krishnendu Khan

Krish obtained his PhD from India in Biochemistry following which he performed post-doctoral work in Germany and the US. Prior to joining West, Krish was involved in the commercialization of novel biologics and diagnostics. Currently, Krish is a subject matter expert in cell and gene therapy and leading West’s initiatives in this space.